ContactCredit ReportFinancialsPeopleOwnershipLatest ActivityMutual CompaniesDocumentsRepayment History

Ingenza Biologics Limited

Ingenza Biologics Limited is a dormant company incorporated on 6 June 2012 with the registered office located in . Ingenza Biologics Limited was registered 13 years ago.
Status
Dormant
Dormant since 8 years ago
Company No
SC425526
Private limited company
Scottish Company
Age
13 years
Incorporated 6 June 2012
Size
Micro
Turnover is under £1M
Balance sheet is under £500,000
Under 10 employees
Confirmation
Submitted
Dated 6 June 2025 (3 months ago)
Next confirmation dated 6 June 2026
Due by 20 June 2026 (9 months remaining)
Last change occurred 3 years ago
Accounts
Submitted
For period 1 May30 Apr 2024 (1 year)
Accounts type is Dormant
Next accounts for period 30 April 2025
Due by 31 January 2026 (4 months remaining)
Contact
Address
Ingenza Limited
Moubray Building
Edinburgh Technopol
Milton Bridge
EH26 0GB
Scotland
Address changed on 2 May 2025 (4 months ago)
Previous address was Roslin Innovation Centre,Charnock Bradley Building Easter Bush Campus Bush Farm Road Roslin EH25 9RG Scotland
Telephone
Unreported
Email
Unreported
Website
Unreported
People
Officers
2
Shareholders
3
Controllers (PSC)
2
PSC • Director • British • Lives in Scotland • Born in May 1959 • Research Scientist
Director • Financial Controller • British • Lives in UK • Born in Jul 1970
Mr Jaymin Ghanshyam Amin
PSC • British • Lives in UK • Born in Jul 1970
Shareholders, PSCs & Group Structure
See who truly controls a company with full PSC, Shareholder, and Group Structure exploration
Mutual Companies
Amprologix Limited
Ian Fotheringham is a mutual person.
Active
Ingenza Limited
Ian Fotheringham is a mutual person.
Active
Ingenza Holdings Ltd
Ian Fotheringham is a mutual person.
Active
Financials
Net Assets, Total Assets & Total Liabilities (2015–2024)
Period Ended
30 Apr 2024
For period 30 Apr30 Apr 2024
Traded for 12 months
Cash in Bank
Unreported
Same as previous period
Turnover
Unreported
Same as previous period
Employees
Unreported
Same as previous period
Total Assets
£350.48K
Same as previous period
Total Liabilities
-£350.47K
Same as previous period
Net Assets
£10
Same as previous period
Debt Ratio (%)
100%
Same as previous period
Latest Activity
Charge Satisfied
1 Month Ago on 22 Jul 2025
Confirmation Submitted
2 Months Ago on 9 Jun 2025
Registered Address Changed
4 Months Ago on 2 May 2025
Mr Ian Fotheringham Details Changed
4 Months Ago on 1 May 2025
Dormant Accounts Submitted
8 Months Ago on 6 Jan 2025
New Charge Registered
10 Months Ago on 18 Oct 2024
Confirmation Submitted
1 Year 2 Months Ago on 11 Jun 2024
Dormant Accounts Submitted
1 Year 8 Months Ago on 10 Jan 2024
Confirmation Submitted
2 Years 2 Months Ago on 21 Jun 2023
Dormant Accounts Submitted
2 Years 7 Months Ago on 19 Jan 2023
Get Credit Report
Discover Ingenza Biologics Limited's Credit Score, how much credit you can offer them, and how likely they are to repay you
Documents
Satisfaction of charge SC4255260001 in full
Submitted on 22 Jul 2025
Confirmation statement made on 6 June 2025 with no updates
Submitted on 9 Jun 2025
Director's details changed for Mr Ian Fotheringham on 1 May 2025
Submitted on 2 May 2025
Registered office address changed from Roslin Innovation Centre,Charnock Bradley Building Easter Bush Campus Bush Farm Road Roslin EH25 9RG Scotland to Ingenza Limited Moubray Building Edinburgh Technopol Milton Bridge EH26 0GB on 2 May 2025
Submitted on 2 May 2025
Accounts for a dormant company made up to 30 April 2024
Submitted on 6 Jan 2025
Registration of charge SC4255260001, created on 18 October 2024
Submitted on 28 Oct 2024
Confirmation statement made on 6 June 2024 with no updates
Submitted on 11 Jun 2024
Accounts for a dormant company made up to 30 April 2023
Submitted on 10 Jan 2024
Confirmation statement made on 6 June 2023 with no updates
Submitted on 21 Jun 2023
Accounts for a dormant company made up to 30 April 2022
Submitted on 19 Jan 2023
Repayment History
Understand how businesses repay their debts and see how they're performing year‐on‐year